Although most T-cells normally react to one specific antigen, studies in MS and long-term EBV carriers have shown that a high proportion of EBV-specific CD4+ and CD8+ T-cells are polyfunctional cells (PFCs) (58). The gene discussed is CD4; the disease is myeloid sarcoma.